Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015

BACKGROUND: In 1980, human diploid cell vaccine (HDCV, Imovax Rabies, Sanofi Pasteur), was licensed for use in the United States. OBJECTIVE: To assess adverse events (AEs) after HDCV reported to the US Vaccine Adverse Event Reporting System (VAERS), a spontaneous reporting surveillance system. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Moro, Pedro L., Woo, Emily Jane, Paul, Wendy, Lewis, Paige, Petersen, Brett W., Cano, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943633/
https://www.ncbi.nlm.nih.gov/pubmed/27410239
http://dx.doi.org/10.1371/journal.pntd.0004846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943633/
https://www.ncbi.nlm.nih.gov/pubmed/27410239
http://dx.doi.org/10.1371/journal.pntd.0004846

Ejemplares similares